Key Points The biotech will both contribute to and draw from its findings. It'll also earn revenue from its participation. 10 stocks we like better than Twist Bioscience › Biotech stocks are famously volatile, due to the speculative nature of the drug discovery business. The good news about this is that when one reports good news, it can send its stock into the stratosphere. On Wednesday, Twist Bioscience (NASDAQ: TWST) had an excellent development to divulge and investors plowed into the biotech company's stock. As a result, it finished the week up by more than 31%. Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.